Skip to main content
Log in

It’s a knockout: CCN3 suppresses neointimal thickening

  • Bits and Bytes
  • Published:
Journal of Cell Communication and Signaling Aims and scope

Abstract

The role of CCN proteins in vivo is only just becoming understood. A prototypical member of the CCN family, CCN3 suppresses proliferation. In a study in press, Shimoyama and colleagues show that mice lacking CCN3 have a hyperproliferative response to vascular injury. These data, along with other recent observations, suggest that CCN3 may represent a novel therapy for hyperproliferative diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bleau AM, Planque N, Perbal B (2005) CCN proteins and cancer: two to tango. Front Biosci 10:998–1009

    Article  CAS  PubMed  Google Scholar 

  • Heath E, Tahri D, Andermarcher E, Schofield P, Fleming S, Boulter CA (2008) Abnormal skeletal and cardiac development, cardiomyopathy, muscle atrophy and cataracts in mice with a targeted disruption of the Nov (Ccn3) gene. BMC Dev Biol 8:18

    Article  PubMed  Google Scholar 

  • Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC, Daluiski A, Lyons KM (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130:2779–2791

    Article  CAS  PubMed  Google Scholar 

  • Kawaki H, Kubota S, Suzuki A, Lazar N, Yamada T, Matsumura T, Ohgawara T, Maeda T, Perbal B, Lyons KM, Takigawa M (2008) Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage. J Bone Miner Res 23:1751–1764

    Article  CAS  PubMed  Google Scholar 

  • Leask A (2007) CCN3: a novel function in vivo. J Cell Commun Signal 1:227–228

    Article  PubMed  Google Scholar 

  • Leask A (2009) Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2. J Cell Commun Signal 3:161–162

    Article  PubMed  Google Scholar 

  • Leask A, Abraham DJ (2006) All in the CCN family. J Cell Science 119:4803–4810

    Article  CAS  PubMed  Google Scholar 

  • Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF (2002) CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 22:8709–8720

    Article  CAS  PubMed  Google Scholar 

  • Perbal B (2007) CCN3-mutant mice are distinct from CCN3-null mice. J Cell Commun Signal 1:229–230

    Article  CAS  PubMed  Google Scholar 

  • Perbal B (2008) CCN3: doctor Jekyll and mister Hyde. J Cell Commun Signal 2:3–7

    Article  PubMed  Google Scholar 

  • Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC (2009) CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. Am J Pathol 174:1725–1734

    Article  CAS  PubMed  Google Scholar 

  • Shimoyama S, Hiraoka S, Takemoto M, Koshizaka M, Tokuyama H, Tokuyama T, Watanabe A, Fujimoto M, Kawamura H, Sato S, Tsurutani Y, Saito Y, Perbal B, Koseki H, Yokote K (2010) CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration, in press

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew Leask.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leask, A. It’s a knockout: CCN3 suppresses neointimal thickening. J. Cell Commun. Signal. 4, 109–110 (2010). https://doi.org/10.1007/s12079-010-0086-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12079-010-0086-y

Keywords

Navigation